Offered by: Nemours
Location: Delaware Valley
What is the trial about?
The purpose of this research study is to gather data on the LIPOSORBER® LA-15 System and determine if it is still as safe now as it was before the FDA approval.
Who can participate?
Patients who are receiving treatment with the LIPOSORBER® LA-15 System.
What is involved?
Blood samples will be collected at baseline, at the end of the treatment and at 5 follow-up visits. These blood samples will be collected at the same time as standard of care lab tests and no additional needle stick will be necessary.
Participation will continue throughout the 9 weeks of treatment and for 24 months after your child’s final LIPOSORBER® LA-15 System treatment.
Contact Nemours Clinical Trials
Trial Name: LIPOSORBER® HDE Post Approval Study